ROBINS CHAD M — SEC insider filings
SEC reporting owner CIK 1780649. 32 insider filings on record with FilingPulse; latest filed 2026-11-12.
Transaction summary — filings shown
Covers all 32 filings on record, filed 2020-08-12 to 2026-11-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 125 legs across 28 filings — 3,756,541 shares, $71,193,808 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 64.
- Largest priced transaction: sale of 318,799 shares @ $25.08 ($7,995,479) in Adaptive Biotechnologies Corp, filed 2026-08-19.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | CEO and Chairman, Director | 32 | — | 125 legs · 3,756,541 sh · $71,193,808 | 64 |
Insider filings — ROBINS CHAD M
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-12 | 4 | Adaptive Biotechnologies Corp (ADPT) | Gift (G): 100,000 @ $0 | EDGAR |
| 2026-08-19 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 321,324 @ $6.55 · Sale (S): 318,799 @ $25.08 · Sale (S): 2,525 @ $25.57 · Option exercise (M): 278,676 @ $6.55 · Sale (S): 278,472 @ $24.48 · Sale (S): 204 @ $25.14 · +2 more | EDGAR |
| 2026-04-08 | 4 | Adaptive Biotechnologies Corp (ADPT) | Sale (S): 83,332 @ $14.41 · Sale (S): 37,263 @ $15.19 | EDGAR |
| 2026-03-13 | 4 | Adaptive Biotechnologies Corp (ADPT) | Sale (S): 140,567 @ $13.17 · Sale (S): 329,600 @ $13.17 | EDGAR |
| 2026-03-06 | 4 | Adaptive Biotechnologies Corp (ADPT) | Grant/award (A): 127,813 @ $0 · Grant/award (A): 709,220 @ $0 | EDGAR |
| 2026-03-03 | 4 | Adaptive Biotechnologies Corp (ADPT) | Sale (S): 182,891 @ $15.99 · Sale (S): 289,024 @ $15.82 · Sale (S): 50,703 @ $15.49 · Sale (S): 2,380 @ $16.15 | EDGAR |
| 2026-02-04 | 4 | Adaptive Biotechnologies Corp (ADPT) | Sale (S): 124,998 @ $18.44 | EDGAR |
| 2026-01-07 | 4 | Adaptive Biotechnologies Corp (ADPT) | Sale (S): 124,998 @ $15.59 | EDGAR |
| 2025-12-01 | 4 | Adaptive Biotechnologies Corp (ADPT) | Sale (S): 35,736 @ $19.68 · Sale (S): 124,998 @ $18.94 | EDGAR |
| 2025-11-12 | 4 | Adaptive Biotechnologies Corp (ADPT) | Sale (S): 86,161 @ $14.73 · Sale (S): 1,237 @ $14.57 · Sale (S): 1,867 @ $15 | EDGAR |
| 2025-03-06 | 4 | Adaptive Biotechnologies Corp (ADPT) | Grant/award (A): 355,000 @ $0 · Sale (S): 81,206 @ $6.98 · Sale (S): 36,145 @ $6.99 · Grant/award (A): 247,117 @ $0 · Sale (S): 102,218 @ $7.64 | EDGAR |
| 2025-02-21 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 186,080 @ $6.32 · Sale (S): 186,080 @ $8.46 · Option exercise (M): 99,107 @ $6.32 · Sale (S): 99,107 @ $8.44 · Option exercise (M): 186,080 (derivative) @ $0 · Option exercise (M): 99,107 (derivative) @ $0 | EDGAR |
| 2025-02-18 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 100,287 @ $6.32 · Sale (S): 100,287 @ $8.44 · Option exercise (M): 158,921 @ $6.32 · Sale (S): 158,921 @ $8.46 · Option exercise (M): 211,160 @ $6.32 · Sale (S): 211,160 @ $8.50 · +3 more | EDGAR |
| 2024-03-06 | 4 | Adaptive Biotechnologies Corp (ADPT) | Grant/award (A): 354,610 @ $0 · Sale (S): 5,879 @ $3.44 · Sale (S): 42,794 @ $3.43 | EDGAR |
| 2023-03-08 | 4 | Adaptive Biotechnologies Corp (ADPT) | Grant/award (A): 354,610 @ $0 | EDGAR |
| 2022-03-09 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 14,815 @ $6.32 · Sale (S): 500 @ $12.22 · Sale (S): 14,315 @ $11.53 · Option exercise (M): 14,815 @ $6.32 · Sale (S): 14,815 @ $11.38 · Option exercise (M): 14,815 @ $6.32 · +4 more | EDGAR |
| 2022-03-08 | 4 | Adaptive Biotechnologies Corp (ADPT) | Grant/award (A): 247,117 @ $0 · Sale (S): 4,424 @ $12.01 | EDGAR |
| 2021-09-10 | 4 | Adaptive Biotechnologies Corp (ADPT) | Sale (S): 11,742 @ $38.34 · Sale (S): 2,004 @ $39.11 · Sale (S): 24,753 @ $38.42 · Sale (S): 4,902 @ $38.37 · Sale (S): 98 @ $39.09 | EDGAR |
| 2021-07-14 | 4 | Adaptive Biotechnologies Corp (ADPT) | Sale (S): 1,501 @ $38.24 | EDGAR |
| 2021-06-17 | 4 | Adaptive Biotechnologies Corp (ADPT) | Sale (S): 19,100 @ $38.22 · Sale (S): 900 @ $39.23 · Sale (S): 4,745 @ $38.13 · Sale (S): 1,000 @ $38.55 · Sale (S): 4,255 @ $39.76 | EDGAR |
| 2021-04-08 | 4 | Adaptive Biotechnologies Corp (ADPT) | Sale (S): 1,600 @ $41.08 · Sale (S): 2,200 @ $42.48 · Sale (S): 1,200 @ $43.08 · Sale (S): 3,900 @ $40.61 · Sale (S): 1,100 @ $41.45 · Sale (S): 2,943 @ $42.04 · +2 more | EDGAR |
| 2021-03-19 | 4 | Adaptive Biotechnologies Corp (ADPT) | Sale (S): 1,901 @ $43.22 · Sale (S): 1,295 @ $44.03 · Sale (S): 1,804 @ $45.25 · Sale (S): 1,926 @ $41.90 · Sale (S): 2,604 @ $42.81 · Sale (S): 470 @ $43.78 · +2 more | EDGAR |
| 2021-03-08 | 4 | Adaptive Biotechnologies Corp (ADPT) | Grant/award (A): 68,681 @ $0 · Grant/award (A): 171,703 (derivative) @ $0 | EDGAR |
| 2021-02-10 | 4 | Adaptive Biotechnologies Corp (ADPT) | Sale (S): 7,314 @ $61.40 · Sale (S): 2,686 @ $62.20 · Sale (S): 5,840 @ $62.07 · Sale (S): 4,160 @ $63.23 · Sale (S): 795 @ $61.51 · Sale (S): 6,801 @ $62.56 · +2 more | EDGAR |
| 2021-01-28 | 4 | Adaptive Biotechnologies Corp (ADPT) | Sale (S): 3,850 @ $62.51 · Sale (S): 2,524 @ $63.63 · Sale (S): 3,526 @ $64.52 · Sale (S): 100 @ $65.23 · Sale (S): 1,879 @ $54.63 · Sale (S): 1,000 @ $56.26 · +7 more | EDGAR |
| 2021-01-21 | 4 | Adaptive Biotechnologies Corp (ADPT) | Sale (S): 8,300 @ $70.42 · Sale (S): 100 @ $71.14 | EDGAR |
| 2020-12-30 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 16,250 @ $0.33 · Sale (S): 13,542 @ $60.71 · Sale (S): 1,108 @ $61.48 · Sale (S): 1,500 @ $62.60 · Sale (S): 100 @ $63.41 · Option exercise (M): 16,790 @ $0.33 · +9 more | EDGAR |
| 2020-11-19 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 16,680 @ $0.33 · Sale (S): 11,047 @ $45.84 · Sale (S): 5,633 @ $46.68 · Option exercise (M): 16,680 @ $0.33 · Sale (S): 1,200 @ $46.68 · Sale (S): 2,000 @ $47.64 · +9 more | EDGAR |
| 2020-10-08 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 18,280 @ $0.33 · Sale (S): 10,178 @ $48.99 · Sale (S): 8,102 @ $49.83 · Option exercise (M): 50,000 @ $0.33 · Sale (S): 1,200 @ $49.40 · Sale (S): 48,800 @ $50.20 · +6 more | EDGAR |
| 2020-10-01 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 1,900 @ $0.33 · Sale (S): 1,900 @ $50.18 · Option exercise (M): 600 @ $0.33 · Sale (S): 600 @ $50.05 · Option exercise (M): 1,900 (derivative) @ $0 · Option exercise (M): 600 (derivative) @ $0 | EDGAR |
| 2020-09-18 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 16,680 @ $0.33 · Sale (S): 6,180 @ $45.47 · Sale (S): 5,000 @ $46.45 · Sale (S): 5,100 @ $47.46 · Sale (S): 400 @ $48.26 · Option exercise (M): 16,680 @ $0.33 · +8 more | EDGAR |
| 2020-08-12 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 16,680 @ $0.33 · Sale (S): 16,680 @ $37.63 · Option exercise (M): 16,680 @ $0.33 · Sale (S): 4,937 @ $36.51 · Sale (S): 9,743 @ $37.40 · Sale (S): 2,000 @ $37.96 · +7 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1780649 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs